Gland Pharma
GLAND.NS
$20.73
Share price
-0.59%
Change (1 day)
23.91%
Change (1 year)
Categories
Gland Pharma (GLAND.NS) - Cash on Hand
Cash on Hand as of September 2023 : $0.26 B
According to Gland Pharma
's latest financial reports the company has $0.26 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Gland Pharma - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $0.45 B | 7.87% |
| 2022-03-31 | $0.42 B | 3.93% |
| 2021-03-31 | $0.40 B | 134.9% |
| 2020-03-31 | $0.17 B | 67.65% |
| 2019-03-31 | $0.10 B | 3.8% |
| 2018-03-31 | $0.10 B |